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INTRODUCTION 
 Folic acid is an essential vitamin which has been known 
in recent 50 years. It is synthetic form of folates which are 
substantial parts of many biochemical processes in the 
human body (Jackson, 2006). In the period of rapid 
growth of organism or in cell growth, body’s demands for 
folate increase. Fortification of foods with folic acid for 
population in the world is still discussed. Its impact in 
neonatal period varies even in premature newborns. 
Substitution of folic acid is one of the important parts in 
the comprehensive treatment of anaemia in premature 
newborns (Hoffbrand and Weir, 2001). It is also a 
component of artificial milk formulae or breast milk 
following mother’s intake. To determine optimal doses for 
each age group is difficult. Other influence should also be 
considered. On the other hand excessive intake of folic 
acid is not a concern as folate is water-soluble and easily 
excreted by kidneys when in excess but on the other side 
growing organism of preterm newborn and disruption of 
metabolic balance could be potential risks for optimal 
development (Hybenova, 2012).  
 In the beginning of 20
th
 century, the link between folic 
acid deficiency and anaemia was assumed. Among the first 
who explored these findings was the English Lucy Wills  
in 1931. She left for India and investigated macrocytic 
anaemia in pregnancy, prevalent in female textile workers. 
Wills and Evans reported cases of patients with tropical 
megaloblastic anaemia who were treated with crude liver 
extract (Hoffbrand and Weir, 2001). The name of folic 
acid comes from the Latin word folium because it was 
isolated from spinach leaves in 1941. Folic acid is a 
synthetic form of folate used in nutritional supplements or 
food fortification. Folate exists as many structural forms, 
natural occurring and synthetic, which are known as 
vitamin B9. The active form is used at the cellular level for 
DNA synthesis and the regulation of homocysteine among 
other functions (Schiff, 2011).  
Rich sources of folate are liver, yeast extracts and green 
leafy vegetables such as spinach, kale, beans, cabbage and 
broccoli and also pork, poultry, shellfish and liver 
(Jackson, 2006). In some countries as United States the 
folic acid intake can come from multiple sources including 
supplements enriched cereal grain products or other types 
of fortified food (Crider et al., 2011).    
 Folates are an integral part of important biochemical 
processes in the human body.  Folate-mediated one-carbon 
metabolism is essential for metabolic processes in 
organism. The most important functions are nucleotide 
biosynthesis, methionine biosynthesis, and cellular 
methylation reactions (Beaudin and Stover, 2007). In 
organism folates can be absorbed as one-carbon forms of 
tetrahydrofolate or polyglutamyl tetrahydrofolate. Folate 
polyglutamates are broken down in the gut by folate 
conjugase in the mucosal brush borders to the 
monoglutamate forms. In this process is reduced the bio-
availability of natural folates (Jackson, 2006). The 
monoglutamates are subsequently absorbed and converted 
to 5-methyltetrahydrofolate. Synthetic folic acid is not 
conjugated and is therefore more bio-available. Before it 
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Folic acid is an essential vitamin which has been known in recent 50 years. It plays an important role in period of 
neurogenesis. The substitution of folic acid is one of the important parts in the complex treatment of anaemia in premature 
newborns. It is also a component of artificial milk formulae or breast milk following mother’s intake. Fortification of foods 
with folic acid for population in the world is still discussed. To determine optimal dose of folic acid in premature newborns 
is difficult. Daily recommended doses of folic acid in infants under the six months were identified. The needs of folic acid 
in newborns vary. It depends upon the gestational age, body reserves at birth or maternal status of folates during gravidity. 
On the other hand there is a risk of accumulation of unmetabolised folic acid in circulation of newborns after mandatory 
folic acid fortification in some countries, which were reported in some studies. The safe upper limits of folic acid intake in 
premature newborns are not known.  
In this review article authors inform about the clear positive effect of folic acid in prenatal and neonatal period, but 
excessive doses of folic acid could present risk of accumulation and possible adverse effects. To follow up these notions 
further studies are required. 
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can become active, folic acid has to be reduced in cells to 
dihydro forms and tetrahydro forms, which are chemically 
unstable. The reduction is catalysed by dihydrofolate 
reductase and tetrahydrofolate is then converted to 5-
methyltetrahydrofolate, the form found in the circulation. 
These reduced and polyglutamylated forms are essential 
for the DNA (deoxyribonucleic acid) biosynthesis. Also 
vitamin B12 is required in as co-factor in the methylation 
cycle. The methylation cycle and DNA cycle regenerate 
tetrahydrofolate (Gregory, 1997). For healthy embryonic 
growth the optimal folate status in cells is needed to secure 
optimal DNA methylation status. It is also known that the 
aging process by itself is accompanied by alterations in 
DNA methylation. Age and reduced folate intake can 
alter folate metabolism (Kim et al., 2009).  
Also some polymorphism in gene for metabolism of folate 
can interact on RBC folate. Interaction between the DHFR 
polymorphism and folic acid intake was also seen with 
respect to RBC folate. It suggests a functional DHFR 
polymorphism, because it limits assimilation of folic acid 
into cellular folate stores at high and low folic acid intakes 
(Kalmbach et al., 2008). Some single-nucleotide 
polymorphism in MTHFR genes are considered to be risk 
factors for NTD (Evinova et al., 2012). The genetic 
polymorphisms of the MTHFR can be also associated with 
some neuropsychiatric disorders, such as major depressive 
disorders (Capra et al., 2013). 
Folates and vitamin B12 play an important role in 
methylation cycle. In the liver it is performed via recycling 
homocysteine (Pristoupilova et al., 1999).  
 
DISCUSSION 
 The benefits of intake of folic acid in periconceptional 
period were reported. The folic acid supplementation in 
periconceptional period decreases the recurrent risk of 
neural tube defects significantly by 85-100 % (Gross and 
Collins, 2007). Daily dose of 400 µg of folic acid during 
pregnancy is recommended for reduction of neural tube 
defects and oro-facial clefts (Canfield et al., 2005; Wilcox 
et al., 2007; Johnston, 2009). Due to several studies in the 
prevention of NTD the periconceptual use of folic acid 
(0,4 mg) per day was recommended by World Health 
Organisation. 
Bánhidy at al. (2011) reported the reduction of structural 
birth defects in offsprings of pregnant women with 
diabetes mellitus type 1 after folic acid supplementation. 
They described it in specific congenital anomalies such  as 
renal dysgenesis, obstructive anomalies of urinary tract, 
cardiovascualar anomalies and caudal dysplasia sequence. 
Relevant decrease in incidence of neural tube defect by 
more than 49 % in northern Jordan after folic acid 
fortification of flour was reported by Amarin and 
Obeidat (2010).  
 In South Africa through the program of folic acid 
fortification of staple foods was for the first time observed 
in African population a benefit in prevention of neural tube 
defects. It was  significant decline of neural tube defects 
by 30.5 % and spina bifida by 41.6 % compared to 10.9 % 
for anencephaly (Sayed et al., 2008). Distribution of 
neural tube defects shows considerable geographical and 
ethnic variation (Gupta and Gupta, 2004). Some limiting 
factors are seasonal and geographic diferencies, but also 
cultural and ethnical variabilities (Zhu and Ling, 2008; 
Hoyo et al., 2011). Hoyo at al. (2011) assumed that 
Caucasian race and ethnicity, advanced maternal age and 
higher education represent greater wherewithal to 
suplemental folic acid access.    
 The specific group includes newborns and mostly very 
low birth weight newborns. Supplementation depends 
upon the gestational age, which is related to the placental 
transfer. Body reserves at birth, vitamin content of breast 
milk with maternal status interact with total amounts of 
folate in newsborn´s blood (Jain, 1994). The influence of 
breastfeeding on folate and cobalamine status was 
reported. Folate was positively correlated with duration of 
exclusive breastfeeding. On the other side low cobalamin 
status is a characteristic finding in breastfed children (Hay 
et al., 2012). Beneficial effect of supplementation with 
folate throughout lactation were documented on folate-
supplemented women had lower total homocysteine and 
higher folate levels (Ramlau-Hansen et al., 2006). 
In some developing countries folic acid and iron 
supplementation of pregnant woman could be beneficial to 
prevent children’s malnutrition. Early childhood stunting 
predicts poor human capital including decreased offspring 
birth weight and shorter adult height (Sachdev, 2012). The 
prenatal supplementation with folic acid decrease risk of 
low birth weight in newborns (Takimoto et al., 2011; 
Peña-Rosas et al., 2012). In some countries young woman 
with low socioeconomic status has limited accesses to 
prenatal care and adequate nutrition during pregnancy. 
Maternal and newborn health status could be improved by 
reinforcing the use of folate-enriched diet (Couto et al., 
2007).  
 The requirement of periconceptual supplementation with 
folate was documented repeatedly. Risk factors associated 
with birth defects of central nervous system include 
deficiency of folate supplementation, cigarette smoking 
and exposure to x-rays (Raza et al., 2012). In some 
countries maternal micronutrient supplementation does not 
have impact on early neonatal morbidity (Christian et al., 
2008). On the other side pertinent ongoing intervention as 
delaying early child birth, adequate antenatal care and 
maternal iron-folate supplementation are beneficial but 
have sub-optimal coverage (Sachdev, 2012). Also the 
folate supplementation during pregnancy can lead to 
preventing allergic diseases in childhood. To follow up 
these notions further studies are required (Peroni et al., 
2012). Intake of folic acid supplementation around the 
time of conception can protect against neurodevelopmental 
disorders as autism spectrum disorders. The use of prenatal 
folic acid supplements was associated with a lower risk of 
autistic disorder in Norwegian mother (Surén et al., 
2013).  The supplementation of folic acid as a part of 
comprehensive treatment with erytropoietin, intravenous 
iron and vitamin B12 reduce the need for transfusion in 
extremely low birth weight newborns (Haiden et al., 
2006; Eghbalian a Monsef, 2005).  
 In last ten years folic acid is conjugated with specific 
anticancer drugs, which are used for treatment of ovarian, 
breast and lung cancer (Pribylova et al., 2010).  
The needs of folic acid in newborns vary. Current 
recommendations of folic acid intake after birth are 
diferent compared with older. Rapid growth of organism 
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or cell growth, body’s demands for folate are increasing 
after birth. It is influenced by several factors on the 
mother’s side, as well as on the newborn’s side or other 
associated complications. Daily recommended doses for 
infants under six months are 60 µg of folic acid in Slovak 
Republic (Kajaba et al., 1997). Also other researchers 
reported the lower reference nutrient intake for children 
under the first year of life with 60 µg of folic acid 
(Gregory, 1997). 
 Food fortification is a massive excercise and requires 
multidisciplinary co-operation and on the other side many 
obstacles as financial barriers and centrally processed food 
cannot adopt to this approach (Gupta and Gupta, 2004). 
The mandatory folic acid fortification of food (flour, 
cereals) was initiated in some countries of the world for 
example USA, Canada and Chile (Crider et al., 2011). 
Folic acid fortification in some countries of the world 
refers to the risk of accumulation of unmetabolised folic 
acid in serum. In one week-long study of folate-replete 
adults consuming folic acid-fortified bread, the dose at 
which unmetabolised folic acid appeared in the blood lay 
between 200-400 µg daily (Sweeney et al., 2007). The 
lower limits of detection offered by the electrochemical 
detection allow the analysis of folate form distribution in 
small specimens as human red blood cells and 
lymphocytes. Measurement in biological samples is 
provided by means of fully automated combination of 
afinity chromatography and HPLC with electronical 
detection (Bagley and Selhub, 2000). Currently the 
microbiological assays based on growth of 
microorganisms are used rarely. Highly effective liquid 
chromatography showed better sensitivity and was suitable 
for determination of folate in food samples (Strandler, 
2012). 
 Obligation to monitor unmetabolised amounts of folic 
acid in national programmes of fortification is required. 
A specific group are newborns who intake folates in 
perinatal period and after birth in breast milk, milk 
formulae or human milk fortifiers subsequently. Sweeney 
at al. reported cases of seven newborns with high level of 
unmetabolised folic acid in serum. In that time fortification 
was not mandatory in Ireland and also none of the mothers 
took folic acid supplementation (Sweeney, 2005). In 
preterm newborns the positive effect of human milk 
fortification was singificantly confirmed. It improves the 
growth of preterm very low birth weight babies and 
predominantly of small for gestation babies 
(Mukhopadhyay et al., 2007). On the other side potential 
risks of necrotizing enterocolitis in association have been 
reported. Some authors reported after addiction of human 
milk fortifiers a significant increase in osmolality of breast 
milk (Agarwal et al., 2004). Preterm formula milks and 
breast milk fortifiers provide sufficient folic acid to 
prevent folate deficiency in preterm infants. The 
supplementation may also benefit in preterm newborns to 
reduce the risk of brain injury as a result of decreased 
plasma homocysteine concentration (Jyothi et al., 2007).  
High intakes of folic acid have also been associated with 
theoretical risks of adverse effects. It could delay the 
diagnosis of vitamin B12 deficiency in treating the anaemia 
at high doses of folic acid and lead to irreversible 
neurological damage if treatment with vitamin B12 is not 
provided. The safe upper limit for the intake of folate is 
considered to be 1 mg for adults (Smith et al., 2008). The 
potential of folic acid is to mask pernicious anaemia and 
possibly accelerate the growth of existing cancer after 
mandatory fortification(Sweeney, 2009). The safe upper 
limits in newborns are not known.  
 
CONCLUSION 
 Folates participate in multiple different biochemical 
pathways and their metabolism intersects on an important 
step in one-carbon metabolism. Folate is required in period 
of neurogenesis in brain and spinal cord. Folate deficiency 
may cause disruption of myelination and inflammatory 
processes. Folic acid seems to be protective against 
development of other disease such as atherosclerosis and 
vascular disease. Fortification with folic acid appears to be 
beneficial but after mandatory fortification the low levels 
of circulatory unmetabolised folic acid have been reported. 
On the other side it could be potentially hazardous and 
depends on the type of food, time interval and amounts of 
folic acid and individuality of organism in neonatal age. 
Unmetabolised folic acid in circulation of newborns could 
have potentially adverse effects. Toxicity of folic acid is 
not a concern as folate is water-soluble and easily excreted 
by kidneys when in excess but on the other side growing 
organism of preterm newborn and disruption of metabolic 
balance could be potential risks. More studies are 
necessary to ascertain this issue. 
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